Adipotide
Also known as: FTPP, Prohibitin-TP01
Fat-targeted proapoptotic peptide; homing sequence (CKGGRAKDC) targets prohibitin on adipose vasculature, triggering apoptosis of fat cells.
- Typical dose
- 250 mcg – 1 mg
- Frequency
- once daily
- Route
- Subcutaneous
- Half-life
- 6 hours
- Routes
- Subcutaneous
- Status
- Research chemical: experimental
Benefits
- Targeted fat cell destruction
- Rapid weight loss in primates
- Body recomposition
Dosing
A common research range for Adipotide is 250 mcg to 1 mg once daily. VERY experimental; renal toxicity concern; requires monitoring. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for Adipotide is 5 mg of peptide in 2 mL of bacteriostatic water, giving roughly 2.5 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
Adipotide has an approximate half-life of 6 hours. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.
Storage
2-8°C post-reconstitution.
Reported side effects
- Renal toxicity (dose-dependent)
- Dehydration
- Fatigue
- Frequent urination
Contraindications
- Kidney disease
- Dehydration
- Pregnancy
Track Adipotide with Vial
Vial logs every Adipotide dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Adipotide is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.